DiaSys Corporation - Form 424(b)(3)
|
Filed Pursuant to Rule 424(b)(3) |
|
Registration No. 333-113883 |
DIASYS CORPORATION
Prospectus Supplement
(To Prospectus Dated May 12, 2004)
Prospective
investors should read this prospectus supplement and the related prospectus carefully
before investing in DiaSys Corporation's common stock. Both documents contain
information prospective investors should consider when making an investment decision.
The
attached prospectus relates to the resale of shares acquired by Icon Investors
Ltd. pursuant to an equity line of credit. Because Icon Investors may sell some
or all of these shares, and since there are currently no agreements, arrangements
or understandings with respect to the sale of any of these shares, DiaSys cannot
estimate the actual number of shares that Icon Investors will hold after the completion
of the offering.
The
following provides information concerning the most recent drawdown requested by
DiaSys under the equity line of credit.
|
Date of
Sale
|
|
Shares
Sold
|
|
Average Sale
Price Per Share
|
|
Proceeds
to DiaSys
|
|
|
|
|
|
|
|
|
|
|
|
August 19,
2004 |
|
37,500 |
|
$.40 |
|
$14,832.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DiaSys
may also be required to pay a consulting fee to Capital Management Internationale
in the event total proceeds of sales to Icon exceed $200,000. The fee allocable
to the current draw down would be $741.63.
DiaSys
Corporation's common stock is quoted on the American Stock Exchange under the
symbol DYX. On August 18, 2004 the closing price for one share of DiaSys's common
stock was $0.49.
DiaSys
expects to use the proceeds from the sale of these shares for general and administrative
expenses.
The date of this Prospectus Supplement is August 19, 2004.